Clinical investigations further confirmed that GLP-1RA treatment led to significant improvements in key pulmonary function parameters, including forced expiratory volume in one second (FEV 1 ), forced vital capacity (FVC), and mid-expiratory flow rates (MEF 75 and MEF 50 )
Ro (Roman Health) Ro has built a reputation for clinical rigor that exceeds what many telehealth competitors offer
Always consult with your healthcare provider for personalized advice
Other GLP-1 receptor agonists registered with Australias Therapeutic Goods Administration (TGA) include sulaglutide (sold as Trulicity), liraglutide (sold as Saxenda) and Tiezepatide (sold as Mounjaro), but only Ozempic is subsidised on the Pharmaceutical Benefits Scheme (PBS)
Researchers believe these improvements are largely related to weight loss, improved insulin sensitivity, and overall cardiometabolic health improvements
These affordability measures are essential in ensuring continuity of care and improving therapeutic outcomes